Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.AVEO has closed below upper band by 37.1%. Bollinger Bands are 5.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
2020-03-30 AVEO Stops AML Study on Ficlatuzumab Amid Coronavirus Pandemic AVEO ceases the phase II CyFi-2 study on ficlatuzumab plus high-dose cytarabine for treating patients with relapsed/refractory acute myeloid leukemia to combat the COVID-19 outbreak.
2020-03-27 Aveo bails on ficlatuzumab study amid Covid-19 Citing clinical trial sites' urgent shift towards fighting the COVID-19 pandemic, AVEO Oncology (NASDAQ:AVEO) and collaboration partner Biodesix have decid
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.